Samsung BioLogics shares rise after agrees to make Moderna COVID-19 vaccine

This post was originally published on this site

The agreement was part of Moderna Inc and Novavax (NASDAQ:NVAX) Inc entering into a deal with the South Korean government to manufacture their COVID-19 vaccines.

The wider market was down 0.2% as of 0007 GMT.

Add Comment